Franklin Genomic Advancements ETF
HELX CBOE - exBATS
Franklin Genomic Advancements ETF seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life
Hover to inspectDrag to measure a move← → to step through days
- Dividend yield
- 0.00% Trailing 12 months
- Volatility · 1Y
- 23.9% Above Average
- Beta
- 0.86 vs the market
- 52-week range
- 31.2445.20
How HELX has paid off
Price return over every period, and total return with dividends reinvested, set against price alone.
Return by period
Price · to Oct 12Total return vs price return
Price onlyOver 1 year, HELX returned +30.7% with dividends reinvested — dividends added 0.0 pts to the price move.
How bumpy is the ride?
Return only means something next to the risk taken to earn it. Volatility, drawdowns and market sensitivity over 1 year.
Volatility
Annualized · 1YA typical year sees the price swing about ±24% around its trend.
Drawdown from peak
How far below its previous high the price has been Deepest fall −18.0% on Mar 27, 2026 — 64 days after the previous high
More than 5% below a high 43% of the time.
Market sensitivity
BetaA beta of 0.86 means HELX has moved less than the market.
Trend & momentum
Where the price sits against its moving averages, and how stretched the recent move is.
Price vs moving averages
Uptrend- 12-day average43.04 −1.7%
- 26-day average42.89 −1.4%
- 50-day average42.07 +0.5%
- 200-day average37.90 +11.6%
The price is above 2 of 4 averages. The 50-day average is above the 200-day, a sign of a rising longer-term trend.
Relative strength (RSI)
NeutralRSI compares recent gains with recent losses on a 0–100 scale. Above 70 a move is often considered stretched, below 30 washed out.
Technical indicators describe past prices. They are not a forecast.
Where HELX shows up
Curated themes and indices that hold HELX. Open one to see it in context, or test the whole theme in a portfolio.
About Franklin Genomic Advancements ETF
Franklin Genomic Advancements ETF seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life
- Featured in 3 curated themes
- Ticker
- HELX
- Exchange
- CBOE - exBATS
- ISIN
- US35473P5200
- CUSIP
- 35473P520
- Currency
- U.S. Dollar (USD)
- Country
- USA
- Sector
- Health Care
- Industry
- Research Advancement
- Benchmark
- Russell 3000 Index
All key statistics
Details
Shareas of Oct 12, 2026
Dataas of Oct 13, 2026
Put HELX to the test
See how it would change the return and the risk of a portfolio, with virtual money, before a single real dollar moves.
Data for information only, not investment advice. Past performance does not guarantee future results.